
Reset all filters
01 1BAXTER CORPORATION
02 1BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
03 9ELI LILLY CANADA INC
04 8NOVO NORDISK CANADA INC
05 2Novo Nordisk
06 2Wockhardt UK
Reset all filters
01 1INSULIN
02 2INSULIN (HUMAN)
03 7INSULIN INJECTION HUMAN BIOSYNTHETIC
04 7INSULIN ISOPHANE HUMAN BIOSYNTHETIC
05 1INSULIN NPH HUMAN DNA ORIGIN
06 1INSULIN SEMI SYNTHETIC HUMAN
07 4Insulin
Reset all filters
01 9SOLUTION
02 14SUSPENSION
Reset all filters
01 2AWIQLI
02 1ENTUZITY KWIKPEN
03 1HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)
04 2HUMULIN 30/70 CARTRIDGE
05 1HUMULIN N
06 1HUMULIN N (CARTRIDGE)
07 1HUMULIN N (KWIKPEN)
08 1HUMULIN R
09 1HUMULIN R CARTRIDGE
10 1HYPURIN NPH INSULIN ISOPHANE PORK
11 1HYPURIN REGULAR INSULIN PORK
12 1MYXREDLIN
13 2NOVOLIN GE 30/70
14 2NOVOLIN GE 30/70 PENFILL
15 1NOVOLIN GE NPH
16 1NOVOLIN GE NPH PENFILL
17 1NOVOLIN GE TORONTO
18 1NOVOLIN GE TORONTO PENFILL
19 1PROZINC
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN INJECTION HUMAN BIOSYNTHETIC
Brand Name : HUMULIN 30/70 CARTRIDGE
Dosage Form : SUSPENSION
Dosage Strength : 30UNIT/ML
Packaging : 3ML
Approval Date :
Application Number : 1959212
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN ISOPHANE HUMAN BIOSYNTHETIC
Brand Name : HUMULIN 30/70 CARTRIDGE
Dosage Form : SUSPENSION
Dosage Strength : 70UNIT/ML
Packaging : 3ML
Approval Date :
Application Number : 1959212
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN INJECTION HUMAN BIOSYNTHETIC
Brand Name : HUMULIN R CARTRIDGE
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging : 3 ML
Approval Date :
Application Number : 1959220
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN ISOPHANE HUMAN BIOSYNTHETIC
Brand Name : HUMULIN N (CARTRIDGE)
Dosage Form : SUSPENSION
Dosage Strength : 100UNIT/ML
Packaging : 3.0ML
Approval Date :
Application Number : 1959239
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN ISOPHANE HUMAN BIOSYNTHETIC
Brand Name : NOVOLIN GE 30/70 PENFILL
Dosage Form : SUSPENSION
Dosage Strength : 70UNIT/ML
Packaging : 3ML
Approval Date :
Application Number : 2025248
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN ISOPHANE HUMAN BIOSYNTHETIC
Brand Name : NOVOLIN GE NPH PENFILL
Dosage Form : SUSPENSION
Dosage Strength : 100UNIT/ML
Packaging : 3ML CARTRIDGE
Approval Date :
Application Number : 2024268
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN INJECTION HUMAN BIOSYNTHETIC
Brand Name : NOVOLIN GE 30/70
Dosage Form : SUSPENSION
Dosage Strength : 30UNIT/ML
Packaging : 10ML
Approval Date :
Application Number : 2024217
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN ISOPHANE HUMAN BIOSYNTHETIC
Brand Name : NOVOLIN GE 30/70
Dosage Form : SUSPENSION
Dosage Strength : 70UNIT/ML
Packaging : 10ML
Approval Date :
Application Number : 2024217
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN INJECTION HUMAN BIOSYNTHETIC
Brand Name : NOVOLIN GE 30/70 PENFILL
Dosage Form : SUSPENSION
Dosage Strength : 30UNIT/ML
Packaging : 3ML
Approval Date :
Application Number : 2025248
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
INSULIN INJECTION HUMAN BIOSYNTHETIC
Brand Name : NOVOLIN GE TORONTO PENFILL
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging : 3ML CARTRIDGE
Approval Date :
Application Number : 2024284
Regulatory Info : Schedule D
Registration Country : Canada